PRELUDE CAPITAL MANAGEMENT, LLC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 75 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$97,995
-30.3%
15,053
-8.7%
0.01%
-14.3%
Q4 2022$140,651
+35.2%
16,489
-16.3%
0.01%
+75.0%
Q3 2022$104,000
-41.2%
19,694
-52.8%
0.00%
-20.0%
Q2 2022$177,000
+48.7%
41,700
+22.6%
0.01%
+66.7%
Q1 2022$119,000
+7.2%
34,000
+103.6%
0.00%0.0%
Q4 2021$111,00016,7000.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders